Fulgent Genetics (FLGT) Revenue (2015 - 2026)

Fulgent Genetics has disclosed Revenue across 12 years of filings, most recently posting $85.4 million for Q2 2026.

• In Q2 2026, Revenue rose 4.38% year-over-year to $85.4 million; the TTM figure through Jun 2026 stood at $241.0 million (down 20.52% YoY), while the FY2025 annual figure was $322.7 million, up 13.83% from the prior year.
• Revenue came in at $85.4 million for Q2 2026 at Fulgent Genetics, up from $71.1 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $320.3 million in Q1 2022 to a low of $400000.0 in Q4 2025.
• Average Revenue over 5 years is $89.1 million, with a median of $74.8 million recorded in 2024.
• The largest YoY upside for Revenue was 17.18% in 2025 against a maximum downside of 99.48% in 2025.
• Over 5 years, Revenue stood at $83.6 million in 2022, then slipped by 15.66% to $70.5 million in 2023, then increased by 8.1% to $76.2 million in 2024, then slumped by 99.48% to $400000.0 in 2025, then surged by 21247.25% to $85.4 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $85.4 million in Q2 2026, $71.1 million in Q1 2026, and $400000.0 in Q4 2025.